SCHEMBL6480448

SCHEMBL6480448

N#CCCCc1ccc(C(=O)O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 7/20 0.54
ALDH1A1 P00352 2/20 0.51
MEN1 O00255 1/20 0.51
RARA P10276 1/20 0.51
MAPT P10636 1/20 0.51
MTOR P42345 1/20 0.51
KMT2A Q03164 1/20 0.51
TBXAS1 P24557 2/20 0.45
TP53 P04637 1/20 0.44
TSHR P16473 1/20 0.44
HSD17B10 Q99714 1/20 0.43
PTGER1 P34995 1/20 0.43
PTGER4 P35408 1/20 0.43
PTGER3 P43115 1/20 0.43
PTGER2 P43116 1/20 0.43
GRIN2D O15399 1/20 0.43
GRIN2A Q12879 1/20 0.43
GRIN2B Q13224 1/20 0.43
GRIN2C Q14957 1/20 0.43
ANPEP P15144 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3767589 0.89 ALDH1A1 (0.50) RARBALDH1A1MEN1RARAMAPT
SCHEMBL371605 0.82 RARB (0.71) RARBALDH1A1MEN1RARAMAPT
SCHEMBL133470 0.82 RARB (0.68) RARBALDH1A1MEN1RARAMAPT
SCHEMBL9671911 0.82 MEN1 (0.46) ALDH1A1MEN1KMT2ATP53TSHR
SCHEMBL31747248 0.81 RARB (0.54) RARBALDH1A1MEN1RARAMAPT
SCHEMBL11770480 0.80 RARB (0.56) RARBALDH1A1MEN1RARAMAPT
SCHEMBL8578235 0.80 RARB (0.53) RARBALDH1A1MEN1RARAMAPT
SCHEMBL9472454 0.80 RARB (0.72) RARBALDH1A1MEN1RARAMAPT
SCHEMBL30053056 0.80 RARB (0.72) RARBALDH1A1MEN1RARAMAPT
SCHEMBL28873230 0.80 RARB (0.72) RARBALDH1A1MEN1RARAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050075345-A1 Novel inhibitor compounds specific of secreted non-pancreatic human a<sb>2</sb>phospholipase of group II YANG JI CHEMICAL COMPANY LTD. (KR) 2005-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075345-A1 Novel inhibitor compounds specific of secreted non-pancreatic human a<sb>2</sb>phospholipase of group II AMY2A, PNLIP, IAPP RARB 2571/4885ALDH1A1 3782/4885MEN1 1731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.